Canaccord Genuity Assumes Coverage on Vertex (VRTX) at Hold; Shares Fairly Valued
Get Alerts VRTX Hot Sheet
Price: $515.55 +1.94%
Rating Summary:
38 Buy, 7 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Rating Summary:
38 Buy, 7 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Join SI Premium – FREE
Canaccord Genuity assumes coverage on Vertex (NASDAQ: VRTX) with a Hold. PT $48.
Canaccord analyst, Dr. George Farmer, says, "Supported by early script data trends and a clinical benefit profile providing higher HCV cure rates with shorter treatment duration than previous standard-of-care, we see high expectations for a successful INCIVEK (telaprevir) launch already reflected in VRTX shares. An overwhelmingly large patient target population drives our 2011 and 2012 U.S. sales estimates of $601M and $2.0B, feeding our total revenue estimates of $754M and $2.3B vs. consensus of $724M and $2.2B."
For more ratings news on Vertex click here and for the rating history of Vertex click here.
Shares of Vertex closed at $52.19 yesterday.
Canaccord analyst, Dr. George Farmer, says, "Supported by early script data trends and a clinical benefit profile providing higher HCV cure rates with shorter treatment duration than previous standard-of-care, we see high expectations for a successful INCIVEK (telaprevir) launch already reflected in VRTX shares. An overwhelmingly large patient target population drives our 2011 and 2012 U.S. sales estimates of $601M and $2.0B, feeding our total revenue estimates of $754M and $2.3B vs. consensus of $724M and $2.2B."
For more ratings news on Vertex click here and for the rating history of Vertex click here.
Shares of Vertex closed at $52.19 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Vortex Energy Engages Market Maker
- BMO Capital Resumes Global Net Lease (GNL), Upgrades to Outperform
- Bernstein SocGen Reiterates Outperform Rating on Vertex (VRTX)
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share